Feed EKTAF
EK

Elekta AB (publ)

EKTAF · OTC

$5.21 +0.00% (+$0.00)
1M -6.96%
Market Cap 19.0B kr
P/E Ratio -
Div. Yield 4.91%
ROE 4.61%

Bulios Fair Price

$6.69

28.4% upside

Current Price

$5.21

Undervalued Fair Value Overvalued

According to Bulios Fair Price, EKTAF is currently undervalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
5/9
Valuation
72 /100
Cheap
EV/EBITDA 18.33x
P/FCF 10.14x
P/S 1.15x
Growth
47 /100
Stable
EPS growth 41.01%
Book val. growth 0.41%
Rev. growth 7.39%
Profitability
45 /100
Moderate
Gross margin 38.61%
FCF margin 11.32%
Net margin 2.16%
Quality
8 /100
Poor
ROIC 37.95%
Asset turnover 0.62x
ROE 4.61%
Debt
39 /100
Moderate
Debt/Equity 0.90x
Net debt/EBITDA 3.52x
Current ratio 0.86x
Stability
75 /100
Stable
Beta 0.96x
Profitable years 6
Rev. volatility 8.26%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about EKTAF
Online

Sector

Healthcare

Industry

Medical - Devices

CEO

Jakob Just-Bomholt

Employees

4,102

Headquarters

Stockholm

Upcoming events

25 NOV

Earnings

Upcoming earnings report

61d
04 MAR

Ex-Dividend

Ex-dividend date

160d
10 MAR

Dividend Payment

Payment date

166d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.